EPIGENOMICS AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.512 EUR | -0.26% |
|
+0.27% | -41.03% |
| 04-30 | Epigenomics AG Announces Jens Ravens Leaves as Executive Board Member | CI |
| 03-14 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 7.8B | - | |||||
| 3.53B | - | |||||
| 2.24B | - | |||||
| 1.84B | - | - | - | - | - | |
| 1.66B | - |
